Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54.5M
-
Number of holders
-
235
-
Total 13F shares, excl. options
-
44.1M
-
Shares change
-
-216K
-
Total reported value, excl. options
-
$2.31B
-
Value change
-
-$7.48M
-
Put/Call ratio
-
8.62
-
Number of buys
-
116
-
Number of sells
-
-103
-
Price
-
$52.28
Significant Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q3 2019
257 filings reported holding EBS - Emergent BioSolutions Inc. - Common Stock as of Q3 2019.
Emergent BioSolutions Inc. - Common Stock (EBS) has 235 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.1M shares
of 54.5M outstanding shares and own 81.01% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.7M shares), VANGUARD GROUP INC (4.66M shares), Neuberger Berman Group LLC (2.43M shares), STATE STREET CORP (1.85M shares), EARNEST PARTNERS LLC (1.75M shares), DIMENSIONAL FUND ADVISORS LP (1.5M shares), RICE HALL JAMES & ASSOCIATES, LLC (1.23M shares), SNYDER CAPITAL MANAGEMENT L P (1.18M shares), NORTHERN TRUST CORP (1.07M shares), and RENAISSANCE TECHNOLOGIES LLC (984K shares).
This table shows the top 235 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.